SEC Rule 701 Thresholds and Equity Plan Disclosure Obligations

Rule 701 separates the amount of compensatory equity a private company may sell from the disclosures it must provide. Its sales limit and its $10 million enhanced disclosure threshold are different tests. Managing them as one creates compliance gaps that become visible in a financing or acquisition review, when correcting the record is most disruptive.

What Rule 701 actually is and what problem it solves for private companies

Every grant of stock options, RSUs, or restricted stock is a securities event under the Securities Act of 1933. Registration is required unless an exemption applies. Rule 701 gives private companies an exemption when they issue compensatory equity under a written benefit plan or compensation contract. It applies only to individual compensatory transactions, with capital raising outside its scope. Equity promises made only out loud do not meet the written-plan requirement.

The rule covers ISOs and NQSOs, restricted stock awards, RSUs, SARs, ESPPs, and direct compensatory stock grants. Eligible recipients include employees, directors, officers, consultants, and advisors, but consultants and advisors must be natural persons providing bona fide services unrelated to capital raising or market promotion. That boundary excludes advisor equity for fundraising introductions. Securities sold for investment, grants to entities, equity for finders or broker-dealers, and phantom stock settled only in cash fall outside its scope. Former employees may exercise options granted before they left, but new grants qualify only if they still provide services to the company.

How the "greatest of three" sales limit actually works and why early-stage companies misread it

17 CFR § 230.701(d)(2) sets the aggregate sales limit at the greatest of three amounts. These are a fixed $1 million floor, a percentage of total assets, and a percentage of the outstanding amount of the class of securities being sold. The percentage tests use the most recent balance sheet date. The company does not add the three amounts together. Nor does the fixed dollar amount necessarily constrain a company whose assets or outstanding securities support a larger offering.

If both percentage calculations for an early-stage company fall below $1 million, the fixed floor sets how much it may sell. If a later-stage company's asset-based calculation exceeds the other two amounts, that calculation instead governs its capacity. Instrument valuation then determines how quickly grants consume it. Options count at their exercise price measured at grant, whether or not they are exercised, while RSUs and restricted stock count at sale price or value. Securities priced by formula use fair value at grant or sale.

A higher 409A valuation can therefore make the same option-grant cadence consume capacity faster as exercise prices rise. Timing also changes the calculation. The limit applies to any consecutive 12-month period, so grants clustered around fiscal year-end remain part of overlapping rolling windows. This calculation establishes permitted offering size.

What the $10 million threshold actually triggers — and what it does not

Rule 701(e) requires enhanced disclosure when aggregate sales are more than $10 million in any consecutive 12-month period. A company may sell more if it has enough capacity under the greatest-of-three test and meets the disclosure requirements that apply. Conversely, the threshold does not give a company permission to issue $10 million if its aggregate sales limit is lower.

The statements must be dated no more than 180 days before the sale. Recipients must get the package a reasonable period before the sale date that applies. Preparing documents after the threshold is crossed does not satisfy that timing requirement.

Revised Question 271.12 directs an issuer expecting sales to exceed the threshold to provide disclosure to all participants in the Rule 701 offering during the relevant 12-month period. Forecasting is therefore part of disclosure compliance. The obligation is not limited to recipients whose awards arrive after aggregate sales pass $10 million. For RSUs, the sale date is the grant date rather than settlement, so a December grant cannot wait for settlement disclosures when the company expects to cross the threshold by February.

What the March 2026 SEC guidance changed about how the threshold applies

The SEC's Division of Corporation Finance issued new and revised Compliance and Disclosure Interpretations on March 6, 2026. The guidance addressed multiperiod grants, repricings, RSU timing, post-deregistration exercises, and acquisitions. Its significance extends beyond calculation mechanics. New Question 271.27 states that failure to provide enhanced disclosure a reasonable time before sale results in loss of the exemption for all equity awards granted during the entire 12-month period in which the threshold was exceeded. The consequence is not confined to awards made after the missed disclosure.

Revised Question 271.10 addresses downward option repricing within 12 months of the original grant. The issuer may exclude the original grant's value but must count the repriced option as a new sale on the repricing date. The date shift changes the rolling calculation. A repricing can therefore push a company near the disclosure threshold over it, even though the exercise price has fallen. Companies that repriced options in 2025 or 2026 must re-run the relevant calculations from the repricing date.

Not every March revision introduced a substantive change. Revised Question 271.14 updated the threshold from $5 million to $10 million without changing the financial statement cadence guidance. When enhanced disclosure is required, foreign issuers that rely on Rule 701 cannot use the semi-annual cadence that foreign Exchange Act reporting companies may use. The longstanding freshness requirement effectively calls for quarterly financial statement availability in most cases.

How M&A transactions create Rule 701 disclosure obligations that neither party's team is tracking

The SEC's Question 271.23 states that, following a merger, the acquirer must include securities sold by the target during the same consecutive 12-month period when testing the $10 million disclosure threshold. An acquirer cannot assess its disclosure position using only awards to its own employees. Nor does the target's independent threshold monitoring answer the acquirer's post-merger question.

Each company may have focused on whether its grants fit within its own sales limit, without preparing a combined disclosure-threshold analysis. The transaction changes the inputs to that analysis. Standard equity diligence that covers vesting schedules, option pool size, and 409A defensibility does not, on its own, show the combined rolling total. Both companies' grant histories for the period still need to be checked under Rule 701(e).

The consequences require a careful distinction, however. Question 271.27 states how a single issuer's offering loses the exemption, but the guidance provided does not say that aggregation automatically invalidates both companies' pre-closing grants. That broader conclusion should not be presented as an SEC position. An aggregation requirement overlooked until after closing leaves the acquirer confronting disclosure exposure that its separate-company review did not identify. Resolving that exposure during a transaction adds legal, reputational, and deal risk to an otherwise distinct equity compensation review.

Where the threshold pressure accumulates as companies scale from Series C to pre-IPO

Acquisitions are only one source of threshold pressure. Companies from Series C through pre-IPO also face higher grant values, more recipients, and growth into more states and countries. As exercise prices rise with 409A valuations, the same number of option grants can have higher aggregate sales values. Hiring growth can increase those volumes at the same time. Meanwhile, financial reporting and disclosure processes may still reflect the smaller equity program for which they were designed.

A package that was timely for one grant round may not remain usable for the next because the statements must stay within the 180-day limit. Companies whose financials are not audit-ready must spend more and coordinate more work to get them ready and keep them that way. Geographic expansion adds a separate layer, since state compensatory equity exemptions vary. Some follow Rule 701 closely, while others call for notice filings, fees, or a separate check of state rules.

New Question 271.26 illustrates how disclosure obligations attach to particular periods. Enhanced disclosure is required only for the 12-month period in which the threshold is exceeded. Prior delivery is not a standing clearance. A company exceeding the threshold in successive periods must meet the obligation in each, using disclosures appropriate to the applicable sales. Teams must keep grant forecasts, financial reporting, who needs disclosure, and what states require in step as each changes.

Why manual tracking of Rule 701 obligations fails at scale and what that costs

Spreadsheet-based administration depends on people repeatedly reconciling rolling sales totals, expected grants, financial statement dates, state requirements, and corporate events. Knowledge of the rule is not enough. A calendar-year review may miss an excess in a window beginning in April and ending in March, even when each calendar-year total appears acceptable. A repricing then adds a new sale date and changes which values belong in the calculation. An acquisition introduces another company's history.

Recipient numbers, jurisdictions, grant-round frequency, and events such as repricings, acquisitions, and deregistrations all affect the review burden. How many staff the work needs depends on more than headcount. A single administrator must bring together changing inputs, and which ones count depends on both timing and instrument type. When grant volume is high enough, spreadsheets make that work depend on people repeatedly stepping in by hand, leaving compliance without a connected process.

Failure costs extend beyond government penalties. Retrospective cleanup consumes staff time, while a disclosure failure can expose an entire 12-month period of awards to loss of the exemption. A disclosed violation in a financing or acquisition data room can complicate the transaction timeline and require remediation that delays closing. Public enforcement adds reputational exposure. The underlying failure is often not an unknown legal requirement, but an unmaintained connection between grant activity, threshold forecasting, and timely delivery.

What forward-looking Rule 701 compliance infrastructure actually requires

Build compliance around the grant calendar. A reliable system must keep tracking rolling exposure and forecast whether planned grants and other activity will trigger enhanced disclosure. That requires a connected set of inputs, including prior grants, exercise prices, repricing dates, RSU grant dates, and acquisition target grant history. Finance must also supply balance sheet totals for the asset-based capacity test and financial statement dates for disclosure readiness. These inputs belong in a system that can run the rolling analysis on demand.

Disclosures must be prepared before the sale date that applies. For RSUs, that means before the grant. Financial statements must be recent enough, risk information must show the company's current condition, and the full package must reach the recipients who need it within the required time. Companies granting equity quarterly need a standing preparation and delivery process. Finance teams approaching or exceeding the threshold should plan their close processes around the effective quarterly reporting cadence that statement freshness creates.

The same forward-looking approach belongs in transaction and expansion planning. Rule 701 analysis should sit in the securities law diligence workstream with 409A defensibility and option plan documentation. State blue sky analysis for compensatory equity should form part of the hiring expansion checklist. Platform consolidation serves a specific purpose here. By connecting payroll, HR, and finance inputs to threshold monitoring and disclosure delivery, it can make the workflow itself responsible for keeping those dependencies aligned, instead of leaving an administrator to reconstruct them when a transaction is already under way.